TNFRSF12A and breast carcinoma: Therefore, we suggest that intrinsic subtypes of breast cancer plus FN14 and GRP94 expression can provide a reliable assessment of BrM risk, facilitating early diagnosis through follow-up of the patient’s evolution (Figure 3).